GHK-Cu

GHK-Cu is commonly considered in provider-directed programs focused on the following areas of interest:

• Tissue Repair and Regenerative Wellness — Often considered in provider-directed programs designed to support tissue response and regenerative wellness objectives.

• Skin Health and Appearance — May be explored within programs focused on skin health, appearance, and healthy-aging wellness goals.

• Recovery Support — May be considered for patients whose goals include recovery following strenuous physical activity or musculoskeletal stress.

GHK-Cu should be evaluated against applicable prescribing information. Information provided by ALML is intended for healthcare professionals and does not replace independent clinical judgment.

GHK-Cu is a naturally occurring copper-binding peptide that has been studied for its association with tissue response and regenerative processes. Areas of biological activity include:

Areas being studied include:

• Tissue Repair and Remodeling — GHK-Cu has been studied for its association with cellular processes involved in tissue repair and remodeling, areas of interest in recovery and regenerative research.

• Collagen and Extracellular Matrix — Research has investigated potential effects on collagen synthesis and extracellular matrix components relevant to skin and connective tissue.

• Recovery and Regenerative Pathways — Preclinical research has explored potential effects on cellular processes associated with tissue repair and recovery following mechanical stress.

• Inflammatory Signaling — Preclinical studies have investigated potential effects on biological pathways involved in inflammatory responses.

Clinical use of GHK-Cu varies by patient-specific factors and applicable prescribing information. The treating healthcare professional remains responsible for all clinical decision-making. This information is educational and does not establish clinical efficacy for any specific use.

Healthcare professionals should independently evaluate the available evidence, patient-specific factors, potential risks, and applicable regulatory requirements before considering GHK-Cu for a patient.

Include these considerations:

• Patient-Specific Assessment Required — Providers should consider the patient's medical history, current medications, allergies, pregnancy or breastfeeding status, and other relevant clinical factors before use.

• Use Within Approved and Appropriate Context — GHK-Cu should be evaluated against applicable prescribing information and used only where clinically appropriate for the individual patient.

• Monitor Tolerance and Relevant Clinical Factors — Providers should monitor patient tolerance and relevant clinical factors throughout the course of use.

• Treatment Decisions Remain With the Licensed Healthcare Professional — All treatment, prescribing, and dosing decisions remain solely the responsibility of the appropriately licensed healthcare professional.

ALML provides product and educational information for healthcare professionals. This information is not a substitute for prescribing information, pharmacy labeling, applicable law, or independent clinical judgment.

Verified formulations and strengths will be updated based on current pharmacy availability.